Literature DB >> 23444194

New targets for disease modifying osteoarthritis drugs: chondrogenesis and Runx1.

Francisco J Blanco, Cristina Ruiz-Romero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23444194     DOI： 10.1136/annrheumdis-2012-202652

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  14 in total

1.  From Bench to Bedside: Targeted Therapy, Denosumab, and 21st Century Orthopaedics: Targets Abound, But Where Are The Therapies?

Authors:  Benjamin K Potter
Journal:  Clin Orthop Relat Res       Date:  2016-02-12       Impact factor: 4.176

2.  Integrative Metabolic Pathway Analysis Reveals Novel Therapeutic Targets in Osteoarthritis.

Authors:  Beatriz Rocha; Berta Cillero-Pastor; Gert Eijkel; Valentina Calamia; Patricia Fernandez-Puente; Martin R L Paine; Cristina Ruiz-Romero; Ron M A Heeren; Francisco J Blanco
Journal:  Mol Cell Proteomics       Date:  2020-01-24       Impact factor: 5.911

Review 3.  Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use.

Authors:  V B Kraus; F J Blanco; M Englund; M A Karsdal; L S Lohmander
Journal:  Osteoarthritis Cartilage       Date:  2015-04-09       Impact factor: 6.576

Review 4.  Mass spectrometry imaging: a novel technology in rheumatology.

Authors:  Beatriz Rocha; Cristina Ruiz-Romero; Francisco J Blanco
Journal:  Nat Rev Rheumatol       Date:  2016-11-24       Impact factor: 20.543

5.  Mitigation of Articular Cartilage Degeneration and Subchondral Bone Sclerosis in Osteoarthritis Progression Using Low-Intensity Ultrasound Stimulation.

Authors:  Xiaofei Li; Yueli Sun; Zhilun Zhou; Dongye Zhang; Jian Jiao; Minyi Hu; Chaudhry Raza Hassan; Yi-Xian Qin
Journal:  Ultrasound Med Biol       Date:  2018-10-12       Impact factor: 2.998

6.  Local delivery of a carbohydrate analog for reducing arthritic inflammation and rebuilding cartilage.

Authors:  Chaekyu Kim; Ok Hee Jeon; Do Hun Kim; J Jeremy Chae; Lucas Shores; Nicholas Bernstein; Rahul Bhattacharya; Jeannine M Coburn; Kevin J Yarema; Jennifer H Elisseeff
Journal:  Biomaterials       Date:  2015-12-31       Impact factor: 12.479

7.  Neural EGFL like 1 as a potential pro-chondrogenic, anti-inflammatory dual-functional disease-modifying osteoarthritis drug.

Authors:  Chenshuang Li; Zhong Zheng; Pin Ha; Wenlu Jiang; Emily A Berthiaume; Seungjun Lee; Zane Mills; Hsinchuan Pan; Eric C Chen; Jie Jiang; Cymbeline T Culiat; Xinli Zhang; Kang Ting; Chia Soo
Journal:  Biomaterials       Date:  2019-10-12       Impact factor: 12.479

8.  Systems approaches in osteoarthritis: Identifying routes to novel diagnostic and therapeutic strategies.

Authors:  Alan J Mueller; Mandy J Peffers; Carole J Proctor; Peter D Clegg
Journal:  J Orthop Res       Date:  2017-04-24       Impact factor: 3.494

9.  Proteomic analysis reveals dexamethasone rescues matrix breakdown but not anabolic dysregulation in a cartilage injury model.

Authors:  Rebecca Mae Black; Yang Wang; André Struglics; Pilar Lorenzo; Viveka Tillgren; Martin Rydén; Alan J Grodzinsky; Patrik Önnerfjord
Journal:  Osteoarthr Cartil Open       Date:  2020-09-05

10.  MicroRNA-365 regulates IL-1β-induced catabolic factor expression by targeting HIF-2α in primary chondrocytes.

Authors:  Hyun Sook Hwang; Su Jin Park; Mi Hyun Lee; Hyun Ah Kim
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.